| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology and Genetics |
1 Division of Oncology, Center for Clinical Sciences Research; Departments of 2 Neurosurgery, 3 Pathology, and 4 Neurology, Stanford University School of Medicine, Stanford, California; and 5 Department of General Neurosurgery, Neurocenter, University of Freiburg, Freiburg, Germany
Requests for reprints: Markus Bredel, Division of Oncology, Center for Clinical Sciences Research, Stanford University School of Medicine, 269 Campus Drive, CCSR-1105, Stanford, CA 94305-5151. Phone: 650-723-5290; Fax: 650-736-1454; E-mail: mbredel{at}stanford.edu.
Gene expression profiling has proven useful in subclassification and outcome prognostication for human glial brain tumors. The analysis of biological significance of the hundreds or thousands of alterations in gene expression found in genomic profiling remains a major challenge. Moreover, it is increasingly evident that genes do not act as individual units but collaborate in overlapping networks, the deregulation of which is a hallmark of cancer. Thus, we have here applied refined network knowledge to the analysis of key functions and pathways associated with gliomagenesis in a set of 50 human gliomas of various histogenesis, using cDNA microarrays, inferential and descriptive statistics, and dynamic mapping of gene expression data into a functional annotation database. Highest-significance networks were assembled around the myc oncogene in gliomagenesis and around the integrin signaling pathway in the glioblastoma subtype, which is paradigmatic for its strong migratory and invasive behavior. Three novel MYC-interacting genes (UBE2C, EMP1, and FBXW7) with cancer-related functions were identified as network constituents differentially expressed in gliomas, as was CD151 as a new component of a network that mediates glioblastoma cell invasion. Complementary, unsupervised relevance network analysis showed a conserved self-organization of modules of interconnected genes with functions in cell cycle regulation in human gliomas. This approach has extended existing knowledge about the organizational pattern of gene expression in human gliomas and identified potential novel targets for future therapeutic development.
This article has been cited by other articles:
![]() |
Y.-K. I. Lau, L. B. Murray, S. S. Houshmandi, Y. Xu, D. H. Gutmann, and Q. Yu Merlin Is a Potent Inhibitor of Glioma Growth Cancer Res., July 15, 2008; 68(14): 5733 - 5742. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Diehn, C. Nardini, D. S. Wang, S. McGovern, M. Jayaraman, Y. Liang, K. Aldape, S. Cha, and M. D. Kuo From the Cover: Identification of noninvasive imaging surrogates for brain tumor gene-expression modules PNAS, April 1, 2008; 105(13): 5213 - 5218. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yu, J. Lin, D. J. Zack, and J. Qian Computational analysis of tissue-specific combinatorial gene regulation: predicting interaction between transcription factors in human tissues Nucleic Acids Res., October 18, 2006; 34(17): 4925 - 4936. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Marguiles, V. S. Klimberg, S. Bhattacharrya, D. Gaddy, and L. J. Suva Genomics and Proteomics of Bone Cancer. Clin. Cancer Res., October 15, 2006; 12(20): 6217s - 6221s. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yu, K. Ganesan, L. D. Miller, and P. Tan A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors. Clin. Cancer Res., June 1, 2006; 12(11): 3288 - 3296. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |